Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.





Physicians monitoring World Cup soccer for transmission of infectious diseases

UCI Health expert says overall risk of Ebola transmission is low

UCI Health infectious disease specialist Dr. Shruti K. Gohil photographed in white coat on a blue background.
Dr. Shruti Gohil is the associate medical director of epidemiology and infection prevention at UCI Health.

IN THE NEWS: Thousands of soccer fans from around the world are traveling to the U.S. to attend this year’s men’s World Cup matches. Public health officials across the county are closely monitoring game attendees for infectious disease, such as Ebola and the hantavirus.

CNBC logo with rainbow peacock and black CNBC letters

Dr. Shruti Gohil, a board-certified infectious disease specialist and the associate medical director of epidemiology and infection prevention at UCI Health, recently spoke with CNBC about why the risk of Ebola transmission is low.

“The overall likelihood of risk is not nonzero, but it’s low, very low, because it is not easy to transmit person to person.”

She also spoke about how the Centers for Disease Control and Prevention (CDC) staff will monitor attendees who have recently returned from places where Ebola and other infectious diseases are more prevalent.

“Individuals are monitored for Ebola not just on the day they arrive back in the country, but for the full incubation period of 21 days.”

Ultimately, public health departments across the nation are working together to actively monitor potential health risks and have systems in place to quickly respond.

Gohil is an associate professor at the UC Irvine School of Medicine. Her clinical interests include hospital epidemiology, infection prevention, communicable disease transmission and multidrug-resistant organism infections.

Gohil has led INSPIRE, a series of national studies to assess patient risk for multidrug-resistant bacterial infections and to prompt physicians to limit the use of extended-spectrum antibacterial drugs in real time. She is a member of The Infectious Diseases Society of America and the Society of Healthcare Epidemiologists in America.

About UCI Health

UCI Health, one of California’s largest academic health systems, is the clinical enterprise of the University of California, Irvine. The 1,461-bed system comprises its main campus UCI Health — Orange, its flagship hospital, the UCI Health — Irvine acute care hospital and medical campus, four hospitals and affiliated physicians of the UCI Health Community Network in Orange and Los Angeles counties and a network of ambulatory care centers across the region. UCI Health — Orange provides tertiary and quaternary care and is home to the only Orange County-based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. Powered by UC Irvine, UCI Health serves 5.6 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us on FacebookInstagramLinkedIn and X (formerly Twitter).